Revised SPC: Biktarvy 50 mg/200 mg/25 mg (bictegravir/emtricitabine/tenofovir alafenamide fumarate) film-coated tablets

The haemodialysis text in various sections of the SPC has been updated in line with the results of week 96 for the Genvoya Study GS-US-292-1825 and week 48 Biktarvy open-label extension.

Source:

electronic Medicines compendium